FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from PLAG1 -Rearranged Adnexal and Salivary Gland Myoepithelial Tumors
Authors:
- Michael MichalMMMichael Michal
- Faizan MalikFMFaizan Malik
- Boulos MansourBMBoulos Mansour
- Travis HatteryTHTravis Hattery
- Carina A DehnerCDCarina A Dehner
- Petr MartinekPMPetr Martinek
- Veronika HájkováVHVeronika Hájková
- Tomáš VaněčekTVTomáš Vaněček
- John S A ChrisingerJCJohn S A Chrisinger
- Isidro MachadoIsidro Machado
- Natálie KlubíčkováNKNatálie Klubíčková
- Vaiyapuri P SumathiVSVaiyapuri P Sumathi
- 4 December 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 32 (3) , 628-644
Abstract
Purpose: Fusion-positive myoepithelial tumors (MET) are clinicopathologically heterogeneous and variably termed mixed tumors and myoepithelial carcinomas. As FET-rearranged METs lack ductal/epithelial differentiation, we test whether FET-rearranged METs are epigenetically distinct from adnexal PLAG1-rearranged METs, which we hypothesize to be analogues of salivary gland METs. Experimental Design: DNA methylation profiling from a multi-institutional cohort of 52 fusion-positive skin, soft-tissue, and bone MET cases was performed and compared with diverse tumor types, including salivary METs. The MET subgroups harbored EWSR1::KLF15, EWSR1/FUS::KLF17, EWSR1::PBX1, EWSR1::PBX3, EWSR1/FUS::POU5F1, SS18::POU5F1, EWSR1::ZNF444, and PLAG1 rearrangements. Pooled clinicopathologic and outcome analysis with new and published cases (total 185) was performed. Results: The MET subgroups showed significant heterogeneity in age, site, and histology. Specifically, EWSR1::KLF15 METs affected predominantly young children (<5 years); EWSR1::PBX1/PBX3 METs were enriched in skin/bone; and EWSR1/FUS::POU5F1, SS18::POU5F1, and EWSR1::KLF15 METs tended to display malignant histology. Conversely, PLAG1-rearranged tumors were predominantly benign, arising in older adults and located in the skin. DNA methylation profiling revealed that FET-rearranged METs were epigenetically related to SS18::POU5F1 METs and FET::NFATC2 sarcomas but entirely distinct from PLAG1-rearranged adnexal and salivary METs. Histologic features were correlated with the degree of genome-wide copy-number variation. The median disease-specific survival was shortest in SS18::POU5F1 (31 months), EWSR1::PBX3 (38 months), and EWSR1::KLF15 (45 months) METs. On multivariate analysis, age <25 years was a significant predictor of worse progression-free survival. Conclusions: FET-rearranged METs are epigenetically unrelated to cutaneous and salivary gland METs, and their malignant counterparts are best classified as sarcomas rather than carcinomas.Keywords
All Related Versions
Funding Information
- U.S. Department of War (HT9425-24-1-0688)
- National Cancer Institute (P50 CA217694)
- National Cancer Institute (P30 CA008748)
- European Union and the state budget of the Czech Republic (CZ.02.01.01/00/23_021/0008828)
- VeloSano Pilot Grant
- Cycle for Survival
- Ministry of Education, Czech Republic (SVV 260652)
- Cooperatio Program, research area SURG
This publication has 54 references indexed in Scilit:
- Cytology‐histology correlation of myoepithelial tumors harboring EWSR1‐POU5F1 fusions: A report of two casesDiagnostic Cytopathology, 2022
- Aggressive myoepithelial carcinoma with EWSR1‐POU5F1 fusion highly responsive to Ewing sarcoma combination chemotherapyCancer, 2020
- EWSR1‐PBX3: A novel gene fusion in myoepithelial tumorsGenes, Chromosomes and Cancer, 2014
- Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival materialGenes, Chromosomes and Cancer, 2014
- Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiationGenes, Chromosomes and Cancer, 2013
- A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpartGenes, Chromosomes and Cancer, 2011
- EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 geneGenes, Chromosomes and Cancer, 2010
- t(19;22)(q13;q12) Translocation leading to the novel fusion gene EWSR1‐ZNF444 in soft tissue myoepithelial carcinomaGenes, Chromosomes and Cancer, 2009
- EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12)Genes, Chromosomes and Cancer, 2005
- Parachordoma.A new clinicopathologic entityCancer, 1977